/Companies

Rejoni

Bedford, US · Founded 2020 · Delaware corporation · 21 employees on LinkedIn · 8 known investors

Find your way into Rejoni

Sign up to see every warm intro you have to Rejoni

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rejoni team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

Founders & leadership

Rejoni was founded in 2020 by Amar Sawhney.

ASAmar Sawhney
Amar SawhneyFounderAmarpreet Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. from IIT Delhi; he previously served as President and CEO of Ocular Therapeutix (NASDAQ: OCUL) and founded multiple medical device companies including Confluent Surgical, Focal Inc., and Access Closure Inc., several of which were acquired by larger healthcare firms.
NS
NICK SVENCERNamed on SEC filing
FK
FARHAD KHOSRAVINamed on SEC filing

Board

TB
TARA BUTLERBoard director

Investors · 8

Funding

SEC filings, press & company announcements

$66.3M disclosed across 3 of 4 rounds · 2020–2026

▶$26.3MraisedOct 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guneesh BatraDirector
  • Amarpreet SawhneyExecutive Officer, Director
  • Nicholas SvencerExecutive Officer, Director
  • Farhad KhosraviDirector
Offering amount
$26.3M
Amount sold
$26.3M
Minimum investment
$10K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedSep 2020 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • AMARPREET SAWHNEYExecutive Officer, Director, Promoter
  • NICK SVENCERExecutive Officer, Director, Promoter
  • TARA BUTLERExecutive Officer, Director, Promoter
  • FARHAD KHOSRAVIExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$15M
Minimum investment
$20K
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Rejoni do?
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
Who founded Rejoni?
Rejoni was founded by Amar Sawhney in 2020.
Who are Rejoni's investors?
Rejoni's investors include Ascension Ventures, Catalyst Health Ventures, ClavystBio, Delos Capital, FemHealth Ventures, Iyengar Capital Partners, Sparta Group, Amed Ventures.
How much funding has Rejoni raised?
Rejoni has disclosed $66.3M raised across 3 of its 4 known rounds.
Where is Rejoni headquartered?
Rejoni is headquartered in Bedford, US.